Update: Cynosure Received FDA Clearance For PicoSure
Andy Batts • Mon, Sep. 29
- Cynosure bagged FDA 510(k) clearance to market PicoSure for the treatment of wrinkles with its new FOCUS lens array.
- In my original article I said that since PicoSure is picosecond-oriented, it is more effective than nanosecond-based devices.
- The approval augments my investment thesis on the company.